Fletcher Payne insider trades: Aptose Biosciences (APTO) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Fletcher reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | APTO | ↑ Buy | 10,000 | $0.68 | $7K | Fletcher Payne 2019 Trust | Sep 21, 2022 (2d) |
| Dec 17, 2015 | CBIO | ↑ Buy | 10,000 | $2.00 | $20K | By Charles and Nancy Payne 2000 Trust | Dec 18, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Fletcher Payne's insider trades
Fletcher Payne is an insider at Aptose Biosciences (APTO). Since Dec 17, 2015, Fletcher has reported 2 open-market purchases worth $27K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (10 filings), option exercises (2 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every APTO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.